The SmartPort injectable port family is designed for extended life, while our Vortex port technology provides better patient outcomes, fewer complications, less nursing time, and lower expenses compared to conventional ports.
The SmartPort+ implantable port is the latest in implantable port innovation from AngioDynamics and combines Vortex and Endexo technology into the port your patient deserves.
The SmartPort+ implantable port is for patients whose providers require long-term access to the central venous system for blood specimen withdrawal and administration of fluids.
The SmartPort+ implantable port improves on standard implantable ports with:
To provide convenience and ease for patients with AngioDynamics implantable ports, AngioDynamics offers a Port Patient App for mobile devices. The app is available from Google Play for Android and the App Store for iOS. It can be found by searching for “AngioDynamics” from any mobile device.
The Port Patient App is a repository of useful information that is needed during medical visits, including the model of the patient’s port, maximum pressures and flow rates for their port, product support information, and important dates such as implantation and previous procedure dates.
AngioDynamics does not provide medical advice, diagnosis, or treatment. The contents of this website, including disease state information, text, graphics, images, and other material (“Content”) are for informational purposes only. The Content is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition and the appropriate treatment for a particular medical condition.
Request a Sales Representative
Reimbursement Resources and C-Code Finder Lookup
SmartPort+ Brochure (For US and Canada Only)
SmartPort+ Brochure (For CE Indication)
SmartPort+ Patient Guide
SmartPort Plastic Patient Guide
Implantable Infusion Port Catalog
The SmartPort CT power-injectable ports offer a tangential outlet and clear-flow technology allowing efficient flushing action to hyper cleanse the entire reservoir. Each model features a lightweight design and a CT-engraved port body for better identification. These ports are clinically indicated for power-injections up to 5mL/sec and a 300-psi pressure limit setting. They are MRI-conditional – 3 Tesla.
To provide convenience and ease for patients with AngioDynamics implantable ports, AngioDynamics offers a Port Patient App for mobile devices. The app is available from Google Play for Android and the App Store for iOS. It can be found by searching for “AngioDynamics” from any mobile device.
The Port Patient App is a repository of useful information that is needed during medical visits, including the model of the patient’s port, maximum pressures and flow rates for their port, product support information, and important dates such as implantation and previous procedure dates.
AngioDynamics does not provide medical advice, diagnosis, or treatment. The contents of this website, including disease state information, text, graphics, images, and other material (“Content”) are for informational purposes only. The Content is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition and the appropriate treatment for a particular medical condition.
Request a Sales Representative
Reimbursement Resources and C-Code Finder Lookup
SmartPort Brochure (For US and Canada Only)
SmartPort CT Patient Guide
Implantable Infusion Port Catalog
1. Stevens B, Barton SE, Brechbill M, et. al. A Randomized, Prospective Trial of Conventional Vascular Ports vs. The Vortex “Clear-Flow” Reservoir Port in Adult Oncology Patients. JVAD 2000; (Summer).
2. The reduction in thrombus accumulation (based on platelet count) is supported by acute in-vitro testing. Pre-clinical in-vitro evaluations do not necessarily predict clinical performance with respect to thrombus formation. Data on file.
3. Third party verification by Pinnacle Healthcare Management.
AngioDynamics, the AngioDynamics logo, SmartPort, SmartPort+, BioFlo, Vortex, Smart Angle, and Engineered For Life are trademarks of AngioDynamics, Inc., an affiliate or subsidiary. All other trademarks are property of their respective owners.
